Vibhavadi Medical Center PCLBKK:VIBHA-R 72 Debt-to-EBITDA is 5.50 as of Mar. 2026, which is 71% above its 10-year median of 3.21. GuruFocus rates BKK:VIBHA-R with a GF Score™ of 72/100 and a GF Value™ of ฿1.60. The stock has 5 warning signs investors should review. Among 476 Healthcare Providers & Services companies, Vibhavadi Medical Center PCL ranks worse than 52.52% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Vibhavadi Medical Center PCL's Debt-to-EBITDA or its related term are showing as below:
BKK:VIBHA-R'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.31 Med: 3.21 Max: 6.22
Current: 2.43
During the past 13 years, the highest Debt-to-EBITDA Ratio of Vibhavadi Medical Center PCL was 6.22. The lowest was 2.31. And the median was 3.21.
BKK:VIBHA-R's Debt-to-EBITDA is ranked worse than 52.52% of 476
companies
in the Healthcare Providers & Services industry
Industry Median: 2.25
vs BKK:VIBHA-R: 2.43
Vibhavadi Medical Center PCL (BKK:VIBHA-R) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Vibhavadi Medical Center PCL Debt-to-EBITDA Related Terms
Vibhavadi Medical Center PCL Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:VIBHA-R vs HCA, THC, DVA: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Vibhavadi Medical Center PCL's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vibhavadi Medical Center PCL Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vibhavadi Medical Center PCL's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Vibhavadi Medical Center PCL's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Vibhavadi Medical Center PCL (BKK:VIBHA-R) has a Debt-to-EBITDA of 5.50 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Vibhavadi Medical Center PCL. This is 71% above median its historical median of 3.21. Over the past decade, Vibhavadi Medical Center PCL's Debt-to-EBITDA has ranged from 2.31 to 6.22. According to the industry distribution chart, Vibhavadi Medical Center PCL ranks #250 out of 476 companies in the Healthcare Providers & Services industry, placing it in the top 52.5%.
Is Vibhavadi Medical Center PCL's Debt-to-EBITDA too high?
Vibhavadi Medical Center PCL's current Debt-to-EBITDA of 5.50 is 71% above median its 10-year median of 3.21. Over the past 10 years, this metric has ranged from a low of 2.31 to a high of 6.22. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.25. Vibhavadi Medical Center PCL's value of 5.50 is 144.4% above this industry median. Based on the distribution chart, Vibhavadi Medical Center PCL ranks #250 out of 476 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Vibhavadi Medical Center PCL has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Vibhavadi Medical Center PCL's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Vibhavadi Medical Center PCL ranks #250 out of 476 companies for Debt-to-EBITDA. This places Vibhavadi Medical Center PCL in the lower half of its industry. The industry median Debt-to-EBITDA is 2.25. Vibhavadi Medical Center PCL's value of 5.50 is 144.4% above this benchmark. Historically, Vibhavadi Medical Center PCL's own Debt-to-EBITDA has ranged from 2.31 to 6.22 over the past decade. While the company's 10-year median is 3.21 vs. the industry median of 2.25, Vibhavadi Medical Center PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.25, based on 476 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vibhavadi Medical Center PCL's current Debt-to-EBITDA of 5.50 is 144.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Vibhavadi Medical Center PCL. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vibhavadi Medical Center PCL's current Debt-to-EBITDA is 5.50, which is 71% above median its own 10-year median of 3.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vibhavadi Medical Center PCL stock overvalued right now?
Vibhavadi Medical Center PCL (BKK:VIBHA-R) has a current Debt-to-EBITDA of 5.50. The stock's GF Value™ is ฿1.60, compared to a current price of ฿1.36 — trading 15% below its estimated fair value. The current Debt-to-EBITDA is 5.50, which is 71% above median its 10-year median of 3.21 and 144.4% above the Healthcare Providers & Services industry median of 2.25. Vibhavadi Medical Center PCL's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Vibhavadi Medical Center PCL (BKK:VIBHA-R), the current Debt-to-EBITDA is 5.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vibhavadi Medical Center PCL (BKK:VIBHA-R) Overvalued in 2026?
Based on GuruFocus' analysis, Vibhavadi Medical Center PCL stock appears to be undervalued.
The current stock price of ฿1.36 is trading 15% below its estimated GF Value™ of ฿1.60.
Key valuation signals for BKK:VIBHA-R:
Debt-to-EBITDA: 5.50 (71% above median its 10-year median of 3.21)
GF Value™: ฿1.60 vs. price of ฿1.36 (15% below fair value)
Industry Position: 144.4% above the Healthcare Providers & Services median (#250 of 476)
No single metric tells the full story. See the BKK:VIBHA-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vibhavadi Medical Center PCL provides the medical services known as Vibhavadi Hospital. The services provided include Pediatric Diseases, General Surgery, Orthopedic Center, General Medicine, Women's Health, Gastrointestinal Center, Cardiology, Neurology, Brain Tumor Surgery, Gamma Knife Radiosurgery for Brain, Cancer, Respiratory Diseases, Plastic Surgery, ENT (Ear, Nose, Throat) Department, Dental Center, Life Style Health Screening Center, Lasik Center, Eye, Hemodialysis Department, Dermatology Center, and Other Clinics and Services. Its segments include Hospital provides general hospital and hospital in social security; and Others provide rental services and rental space. The majority of the revenue is derived from the Hospital segment.
72GF Score
Get the complete analysis for BKK:VIBHA-R
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:VIBHA-R has been successfully added to your 
